drugset / Trial / NCT00150852

Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus.

NCT00150852

Phase 2 Unknown 96 enrolled University Hospital, Geneva
RandomizedParallel-groupDouble-blindPrevention

Summary

The aim of this study is to determine whether vancomycin with cefazoline is superior to vancomycin with placebo in preventing gastrostomy-related wound infection in carriers of methicillin-resistant staphylococcus aureus (MRSA).

Timeline

Start
2004-09
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Vancomycin Other / unclassified Intravenous

Indications